VAXIN INC has a total of 19 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SILENSEED LTD, NOVAVAX INC and REDVAX GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Australia | 2 | |
#6 | China | 2 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Tang De-Chu C | 13 |
#2 | Van Kampen Kent R | 9 |
#3 | Zhang Jianfeng | 6 |
#4 | Jianfeng Zhang | 2 |
#5 | Tang De Chu C | 2 |
#6 | Toro Harold | 2 |
#7 | Harold Toro | 1 |
#8 | Toro Haroldo | 1 |
#9 | Van Kampen Kent Rigby | 1 |
#10 | Kampen Kent R Van | 1 |
Publication | Filing date | Title |
---|---|---|
KR20140123403A | Rapid and prolonged immunologic-therapeutic | |
EP2296700A2 | Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens | |
CN101365484A | Immunization of avians by administration of non-replicating vectored vaccines | |
CA2609276A1 | Rapid production of adenovirus-free recombinant adenovirus vectors | |
AU2003262379A1 | TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH |